Home » Stocks » COMPASS Pathways


Stock Price: $38.39 USD 4.19 (12.25%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $38.00 -0.39 (-1.02%) Oct 23, 7:53 PM

Stock Price Chart

Key Info

Market Cap 1.38B
Revenue (ttm) n/a
Net Income (ttm) -38.15M
Shares Out 33.45M
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $38.39
Previous Close $34.20
Change ($) 4.19
Change (%) 12.25%
Day's Open 34.39
Day's Range 33.35 - 40.00
Day's Volume 2,157,152
52-Week Range 22.51 - 47.29

More Stats

Market Cap 1.38B
Enterprise Value 1.38B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 33.45M
Float n/a
EPS (basic) -0.30
EPS (diluted) -1.14
FCF / Share -0.27
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 373,699
Short Ratio 0.32
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income -21.18M
Net Income -38.15M
Free Cash Flow -17.98M
Net Cash 3.90M
Net Cash / Share 0.11
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC -626.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(69.31% upside)
Current: $38.39
Target: 65.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-21.18-12.50
Net Income-19.61-13.22
Shares Outstanding65.8133.13
Earnings Per Share-0.30-0.40
Operating Cash Flow-17.81-9.80
Capital Expenditures-0.17-0.13
Free Cash Flow-17.98-9.93
Cash & Equivalents24.9822.91
Total Debt21.09-
Net Cash / Debt3.9022.91
Book Value-30.39-14.37
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name COMPASS Pathways PLC
Country United Kingdom
Employees 48
CEO George Jay Goldsmith

Stock Information

Ticker Symbol CMPS
Stock Exchange NASDAQ
Sector Health Technology
Industry Biotechnology
Unique Identifier NASDAQ: CMPS
IPO Date September 18, 2020


COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.